array:19 [ "pii" => "S2173510719300801" "issn" => "21735107" "doi" => "10.1016/j.rxeng.2019.08.001" "estado" => "S300" "fechaPublicacion" => "2019-11-01" "aid" => "1138" "copyright" => "SERAM" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Radiologia. 2019;61:498-505" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 5 "formatos" => array:2 [ "HTML" => 3 "PDF" => 2 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original articles</span>" "titulo" => "Tumour pseudoprogression during nivolumab immunotherapy for lung cancer" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "498" "paginaFinal" => "505" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Pseudoprogresión tumoral en el tratamiento inmunoterápico con nivolumab en el cáncer de pulmón" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 920 "Ancho" => 2167 "Tamanyo" => 89696 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0040" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Mechanism of action of nivolumab. PD-1 (expressed by activated T cells) is blocked by PD-L1 (expressed by tumour cells), thus inhibiting the immune response (A). Nivolumab binds to PD-1 and blocks its interaction with the PD-L1 ligand, which restores the antitumour immunity (B).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Mayoral, E. Castañer, X. Gallardo, M. Andreu, E. Dalmau, Y. Garcia" "autores" => array:6 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Mayoral" ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Castañer" ] 2 => array:2 [ "nombre" => "X." "apellidos" => "Gallardo" ] 3 => array:2 [ "nombre" => "M." "apellidos" => "Andreu" ] 4 => array:2 [ "nombre" => "E." "apellidos" => "Dalmau" ] 5 => array:2 [ "nombre" => "Y." "apellidos" => "Garcia" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0033833819300670" "doi" => "10.1016/j.rx.2019.05.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0033833819300670?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173510719300801?idApp=UINPBA00004N" "url" => "/21735107/0000006100000006/v1_201911220737/S2173510719300801/v1_201911220737/en/main.assets" ]
Journal Information
Vol. 61. Issue 6.
Pages 498-505 (November - December 2019)
Vol. 61. Issue 6.
Pages 498-505 (November - December 2019)
Original articles
Tumour pseudoprogression during nivolumab immunotherapy for lung cancer
Pseudoprogresión tumoral en el tratamiento inmunoterápico con nivolumab en el cáncer de pulmón
M. Mayoral, E. Castañer, X. Gallardo, M. Andreu, E. Dalmau, Y. Garcia
Article information
These are the options to access the full texts of the publication Radiología (English Edition)
Subscriber
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail